About Zhejiang Novus Pharmaceuticals
Zhejiang Novus Pharmaceuticals is a Healthcare company based in Shaoxing (China) founded in 2015, and was acquired by CTI BioPharma in June 2003. Generic drugs, APIs, and dietary supplements are developed and manufactured. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Founded in 2015 as a subsidiary of Zhejiang Medicine, Novus Pharmaceuticals operates in the pharmaceutical sector from Shaoxing, China. Contract manufacturing is provided for soft gel capsules and generic drugs, alongside API production and dietary supplements in softgel and tablet formats. Generic products are planned, while API development and new drug molecules remain in the pipeline.
- Headquarters Shaoxing, China
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website novuspharma.com
- Acquired by CTI BioPharma (Jun 2003)
- Investors
- Acquired byCTI BioPharma
(Jun 2003)
Investors in Zhejiang Novus Pharmaceuticals
Zhejiang Novus Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include CTI BioPharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Targeted small molecule therapeutics for blood cancers are developed. | 1991 | ctibiopharma.com | Seattle, United States |
Investor details for Zhejiang Novus Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Zhejiang Novus Pharmaceuticals
2 dated milestones of Zhejiang Novus Pharmaceuticals across 12 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by CTI BioPharma.
- Founded Zhejiang Novus Pharmaceuticals is founded.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Zhejiang Novus Pharmaceuticals
Zhejiang Novus Pharmaceuticals was founded in 2015.
Zhejiang Novus Pharmaceuticals is headquartered in Shaoxing, China. It is registered at Shaoxing, Zhejiang, China.
Founded in 2015 as a subsidiary of Zhejiang Medicine, Novus Pharmaceuticals operates in the pharmaceutical sector from Shaoxing, China. Contract manufacturing is provided for soft gel capsules and generic drugs, alongside API production and dietary supplements in softgel and tablet formats. Generic products are planned, while API development and new drug molecules remain in the pipeline.
Zhejiang Novus Pharmaceuticals has 1 investor. Key investors include CTI BioPharma.
Yes. Zhejiang Novus Pharmaceuticals was acquired by CTI BioPharma in June 2003.
